As of 2025-12-15, the Relative Valuation of IGM Biosciences Inc (IGMS) is (15.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.27 USD, the upside of IGM Biosciences Inc based on Relative Valuation is -1283.6%.
The range of the Relative Valuation is (9.14) - (17.55) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.3x - 20.0x | 17.0x |
| Forward P/E multiples | 10.4x - 21.7x | 17.2x |
| Fair Price | (9.14) - (17.55) | (15.03) |
| Upside | -819.9% - -1481.6% | -1283.6% |
| Date | P/E |